The 10-day moving average for AMGN crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
The Aroon Indicator for AMGN entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMGN's RSI Oscillator exited the oversold zone, 21 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on AMGN as a result. In 46 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on September 24, 2026. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in 33 of 48 cases over the following month. The odds of a continued upward trend are 69%.
AMGN moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in 191 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Tickeron Profit vs. Risk Rating rating for this company is 7 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.342) is normal, around the industry mean (19.199). P/E Ratio (25.971) is within average values for comparable stocks, (34.793). Projected Growth (PEG Ratio) (2.524) is also within normal values, averaging (5.738). Dividend Yield (0.024) settles around the average of (0.025) among similar stocks. P/S Ratio (5.371) is also within normal values, averaging (4.033).
The Tickeron Price Growth Rating for this company is 12 (best 1 - 100 worst), indicating outstanding price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 15 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The RSI Indicator for IGA moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 22 of the 23 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on IGA as a result. In 80 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
Following a +0.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where IGA advanced for three days, in 243 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
IGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 294 of 342 cases where IGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for IGA turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 35 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
IGA moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IGA crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
AMGN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 89 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 7 | |
SMR RATING 1..100 | 15 | |
PRICE GROWTH RATING 1..100 | 12 | |
P/E GROWTH RATING 1..100 | 27 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AMGN | IGA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 43% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 62% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 69% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 61% | 1 day ago 74% |
| Advances ODDS (%) | 4 days ago 61% | 3 days ago 86% |
| Declines ODDS (%) | 10 days ago 47% | 9 days ago 70% |
| BollingerBands ODDS (%) | N/A | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 47% | 1 day ago 86% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMGN’s FA Score shows that 5 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMGN’s TA Score shows that 5 TA indicator(s) are bullish.
AMGN (@Pharmaceuticals: Major) experienced а +3.15% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.74%. For the same industry, the average monthly price growth was -6.28%, and the average quarterly price growth was +2.55%.
AMGN is expected to report earnings on Nov 03, 2026.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VPLS | 74.20 | 0.04 | +0.05% |
| Vanguard Core Plus Bond ETF (VPLS) | |||
| CEMB | 44.00 | N/A | N/A |
| iShares J.P. Morgan EM Corporate Bond ETF (CEMB) | |||
| MBBB | 20.31 | N/A | N/A |
| VanEck Moody's Analytics BBB Corporate Bond ETF (MBBB) | |||
| SEPM | 33.45 | -0.09 | -0.27% |
| FT Vest U.S. Equity Max Buffer ETF - September (SEPM) | |||
| RMMZ | 13.30 | -0.10 | -0.71% |
| RiverNorth Managed Duration Municipal Income Fund II | |||
A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.
| Ticker / NAME | Correlation To AMGN | 1D Price Change % | ||
|---|---|---|---|---|
| AMGN | 100% | +3.21% | ||
| PFE - AMGN | 51% Loosely correlated | +2.96% | ||
| GILD - AMGN | 48% Loosely correlated | +3.80% | ||
| ABBV - AMGN | 48% Loosely correlated | +3.32% | ||
| BIIB - AMGN | 47% Loosely correlated | +1.72% | ||
| MRK - AMGN | 47% Loosely correlated | +3.80% | ||
More | ||||
A.I.dvisor tells us that IGA and CI have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IGA and CI's prices will move in lockstep.
| Ticker / NAME | Correlation To IGA | 1D Price Change % | ||
|---|---|---|---|---|
| IGA | 100% | -0.10% | ||
| CI - IGA | 15% Poorly correlated | +2.50% | ||
| CSCO - IGA | 14% Poorly correlated | -1.24% | ||
| AMGN - IGA | 11% Poorly correlated | +3.21% | ||
| PEP - IGA | 10% Poorly correlated | +1.55% | ||
| CVX - IGA | 9% Poorly correlated | +1.98% | ||
More | ||||